Back to Archived Journals » Comparative Effectiveness Research » Volume 7

Cost-effectiveness of sunitinib as second-line treatment for gastrointestinal stromal tumor in the People’s Republic of China

Total article views   Abstract views HTML views PDF downloads Totals
5,371 Dovepress* 4,149 1,222+ 388 5,371
Totals 4,149 1,222 388 5,371
*Since 23 January 2017
+Since July 2016

View citations on Google Scholar